Tumor-specific recognition of human myeloma cells by idiotype-induced CD8+ T cells

Blood

Volumn 96, Issue 8, 2000, Pages 2828-2833

  Li, Y ^a   Bendandi, M ^a   Deng, Y ^a   Dunbar, C ^a   Munshi, N ^a   Jagannath, S ^a   Kwak, L W ^a   Lyerly, H K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOLOGY; CASE REPORT; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; HLA MATCHING; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MONONUCLEAR CELL; MYELOMA CELL; PRIORITY JOURNAL; TH1 CELL;

EID: 0034667620     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.8.2828     Document Type: Article

References (18)

1. Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins
2. Idiotype-specific transplantation resistance to MOPC-315: Abrogation by post-immunization thymectomy
3. + T cells and immuno-surveillance of B-cell tumors
4. Anti-idiotypic immunity as a potential regulator in myeloma and related diseases
5. + subsets
6. Anti-idiotypic T-cell activation in multiple myeloma induced by M-component fragments presented by dendritic cells
7. Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: Correlation with diagnosis and disease status
8. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma
9. Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses
10. Transfer of myeloma idiotype-specific T-cell immunity from an actively immunized marrow donor
11. The dendritic cell system and its role in immunogenicity
12. The role of IL-13 in the generation of dendritic cells in vitro
13. + T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
14. Vaccination with irradiated tumor cells engineered to secret murine granulocyte-macrophage colony-stimulating factor sfimulates potent, specific, and long-lasting anti-tumor immunity
15. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response
16. + T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma
17. + T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor
18. Primary myeloma cells growing in SCID-hu mice: A model for studying the biology and treatment of myeloma and its manifestations